Stock Price
2.97
Daily Change
-0.01 -0.17%
Monthly
-4.97%
Yearly
103.08%
Q1 Forecast
2.88

Galectin Therapeutics reported $-2.71M in Interest Income for its fiscal quarter ending in December of 2023.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Galectin Therapeutics USD -2.71M 2.77M Dec/2023
Gilead Sciences USD 88M 15M Sep/2025
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 30.75M 3.97M Dec/2025
Merck USD 96M 27M Sep/2025